If you are part of that large portion of the population - 20% in Europe, 26% in Italy, or about 15.6 million - who suffer from chronic pain, you can finally breathe a sigh of relief is coming to a new drug will finally bring back the smile on his lips.
According to data from recent research on the Doloredoc chronic pain, it affects people between 45 and 65 (55.73%) and is due to chronic low back pain in 55% of respondents (192) and the remaining 45% to chronic pain in the joints (knees, hands, hips). After more than 30 years the first new oral drug for the treatment of chronic pain will be available in pharmacies next month: the Tapentadol (Palex) of Grünenthal - German company founded in the year '50, has always been dedicated to clinical research of products effective against pain.